Revenue
1.16 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 1164315 USD Source
Fundies. English
Ensysce Biosciences, Inc.
EDGARAnnual consolidated revenue for 2025: about USD 5.067M, using the latest reported figures. The previous period, 2024, was about USD 5.21M.
Latest quarter
Operating margin
-221.28%
2026 Q2 · %
Operating cash flow
-1.96 million USD
2026 Q2 · USD
- Cash and cash equivalents
- 677 thousand USD Source
Exact value
676704 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 16.2 million shares Source
Exact value
16227518 shares
Reported share-count change
578.05% · 13.8 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
4.5 million USD
2025-07-01 – 2026-06-30
Operating cash flow
-8.86 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -6280459 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -4414280 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -7806292 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -6280459 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -3500925 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -5463383 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -3500925 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-23.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 6 of 11 periods available· newest 2025-12-31
- Operating income: 8 of 11 periods available· newest 2025-12-31
- Net income: 3 of 11 periods available· newest 2020-12-31
- Operating cash flow: 8 of 11 periods available· newest 2025-12-31
- Capital expenditure: 1 of 11 periods available· newest 2025-12-31
- Total assets: 6 of 11 periods available· newest 2025-12-31
- Total liabilities: 6 of 11 periods available· newest 2025-12-31
- Current assets: 6 of 11 periods available· newest 2025-12-31
- Current liabilities: 6 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 6 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
-2.8%Prior period
USD 5.21 million
–
Current period
USD 5.07 million
–
Exact inputs and evidence
5066650 − 5210031 = -143381 USD
5210031 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source5066650 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 303,592Prior period
−USD 7.5 million
–
Current period
−USD 7.81 million
–
Exact inputs and evidence
-7806292 − -7502700 = -303592 USD
-7502700 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-7806292 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 5.07 million 100% of revenue
- Operating costs Derived USD 15.31 million 302% of revenue
- Operating income −USD 10.24 million −202% of revenue
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow −USD 7.81 million −154% of revenue
- Capital expenditure USD 123,643 2.4% of revenue
- Free cash flow Derived −USD 7.93 million −157% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2020 Operating loss: operating costs were 141% of revenue.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 3931209 | 5544496 Derived | -1613287 | -5924056 Derived | 4310769 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 3531199 | 23401630 Derived | -19870431 | Unavailable | Unavailable | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 2523383 | 26745478 Derived | -24222095 | Unavailable | Unavailable | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 2230520 | 12948707 Derived | -10718187 | Unavailable | Unavailable | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 5210031 | 11940165 Derived | -6730134 | Unavailable | Unavailable | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 5066650 | 15307596 Derived | -10240946 | Unavailable | Unavailable | -7929935 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 5.1M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 3931209 |
|
| 2021 | Revenue | 3531199 |
|
| 2022 | Revenue | 2523383 |
|
| 2023 | Revenue | 2230520 |
|
| 2024 | Revenue | 5210031 |
|
| 2025 | Revenue | 5066650 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-2.8% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | -10.2% |
|
| 2022 | Year over year | -28.5% |
|
| 2023 | Year over year | -11.6% |
|
| 2024 | Year over year | 133.6% |
|
| 2025 | Year over year | -2.8% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -202.1% 2025
Net margin 109.7% 2020
Free cash flow margin -156.5% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -41% |
|
| 2021 | Operating margin | -562.7% |
|
| 2022 | Operating margin | -959.9% |
|
| 2023 | Operating margin | -480.5% |
|
| 2024 | Operating margin | -129.2% |
|
| 2025 | Operating margin | -202.1% |
|
| 2020 | Net margin | 109.7% |
|
| 2021-12-31 | Net margin | Not reported |
|
| 2022-12-31 | Net margin | Not reported |
|
| 2023-12-31 | Net margin | Not reported |
|
| 2024-12-31 | Net margin | Not reported |
|
| 2025-12-31 | Net margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | -156.5% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -7.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -1247342 |
|
| 2021 | Operating cash flow | -8242177 |
|
| 2022 | Operating cash flow | -17887439 |
|
| 2023 | Operating cash flow | -10779982 |
|
| 2024 | Operating cash flow | -7502700 |
|
| 2025 | Operating cash flow | -7806292 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -7.9M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | -7929935 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
61.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 1,992.6% |
|
| 2021 | Liabilities / assets | 149.7% |
|
| 2022 | Liabilities / assets | 168.5% |
|
| 2023 | Liabilities / assets | 124% |
|
| 2024 | Liabilities / assets | 39.6% |
|
| 2025 | Liabilities / assets | 61.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
1.59× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 0.05× |
|
| 2021 | Current assets / current liabilities | 0.95× |
|
| 2022 | Current assets / current liabilities | 0.56× |
|
| 2023 | Current assets / current liabilities | 0.69× |
|
| 2024 | Current assets / current liabilities | 2.42× |
|
| 2025 | Current assets / current liabilities | 1.59× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | USD 2.05 million Exact valueExact value: 2053783 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.24 million Exact valueExact value: -1238263 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 1.07 million Exact valueExact value: -1067296 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.42 million Exact valueExact value: -1424792 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | USD 4.31 million Exact valueExact value: 4310769 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.25 million Exact valueExact value: -1247342 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | Unavailable Not reported for this period. | −USD 8.24 million Exact valueExact value: -8242177 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | Unavailable Not reported for this period. | −USD 17.89 million Exact valueExact value: -17887439 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | −USD 10.78 million Exact valueExact value: -10779982 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | Unavailable Not reported for this period. | −USD 7.5 million Exact valueExact value: -7502700 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | Unavailable Not reported for this period. | −USD 7.81 million Exact valueExact value: -7806292 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 123,643 Exact valueExact value: 123643 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.93 million Calculation and evidence-7806292 − 123643 USD Exact free cash flow: -7929935 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
65 filings · 1,724 latest values · 1,724 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001716947, 1716947, ENSC, LACQ, LACQU, edgar:1716947
Also known as ENSYSCE BIOSCIENCES, INC., ENSYSCE BIOSCIENCES, INC., Ensysce Biosciences, Inc., LEISURE ACQUISITION CORP., LEISURE ACQUISITION CORP., Leisure Acquisition Corp.